adyn

Emerging

Precision birth control test using hormone and genetic data to personalize contraceptive selection; $2.65M from Lux Capital and M13 addressing trial-and-error that leaves millions on wrong contraceptives.

Updated March 2026

Company Overview

About adyn

adyn is a precision medicine company developing personalized birth control solutions through at-home testing kits that analyze hormone levels and genetic risk factors — enabling individuals to choose hormonal contraceptives based on their own biology rather than trial-and-error, addressing a gap where most people cycle through multiple birth control options over years to find what works without causing intolerable side effects. Founded in 2019 and a Y Combinator graduate, adyn raised $2.65 million in seed funding co-led by Lux Capital and M13, with the Birth Control Optimization Test positioned as the first biology-based test for contraceptive personalization.

Business Model & Competitive Advantage

adyn's Birth Control Optimization Test analyzes blood samples for hormone profiles and genetic variants associated with specific contraceptive side effect risks (blood clot risk with estrogen-containing methods, mood effects from synthetic progestins, breakthrough bleeding patterns) and matches results to contraceptive options that the individual's biology is likely to tolerate well. The test translates complex pharmacogenomic and endocrinology research into actionable recommendations that gynecologists and patients can use together to make evidence-based contraceptive decisions.

Competitive Landscape 2025–2026

In 2025, adyn operates in the women's health testing and femtech market with Mira (hormone monitoring), Modern Fertility (now part of Ro), and telemedicine birth control platforms (Nurx, The Pill Club) for personalized hormonal contraceptive guidance. Contraceptive personalization represents an underserved opportunity — despite 100+ million people using hormonal birth control globally, the selection process remains largely empirical (try it, see how you feel, switch if side effects are intolerable). Lux Capital's investment signals deep biotech conviction about the precision medicine angle in reproductive health. The 2025 strategy focuses on direct-to-consumer sales of the test kit, building clinical partnerships with OBGYNs and reproductive endocrinologists, and expanding the test panel to include additional genetic variants relevant to contraceptive outcomes.

Revenue
$2.65M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

adyn is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Not So Random Others

Zeffy

Nonprofit Tech
B2bSaas

Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs

Oda Studio

Real Estate & Property Tech
B2bProptechAi PoweredSaas

Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Cursor

Developer Tools & Platforms
B2bDeveloper ToolsSaasUnicorn

Cursor is an AI-powered code editor built on Visual Studio Code that integrates advanced language models to provide intelligent code completion, generation, debugging, and refactoring capabilities dir

Kindful

Nonprofit Tech
B2bSaasSmb

Kindful is a donor management and fundraising platform designed for nonprofit organizations to manage relationships, track donations, and execute fundraising campaigns. The company serves small to mid

Compare adyn with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For adyn

Claim This Profile

Are you from adyn? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim adyn Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention adyn vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →